Evaluation of Two Different Regimens of Colon Preparations for Advanced Cleaning.

NCT05570669 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2022-10-06

No results posted yet for this study

Summary

Multicenter, prospective, randomized, checked, open label, with blind evaluation, for compare the intestinal cleansing effectiveness of the regimen full-dose delayed (A) of Clensia vs split regimen (B) of Clensia, in patients undergoing endoscopy.

Conditions

  • Colonoscopy

Interventions

DRUG

(Macrogol 4000 52,500 g + Sodium sulphate anhydrous 3,750 g + Simethicone 0,080 g) full dose

Taking the colonoscopy preparation drug (Clensia) in a single administration

DRUG

(Macrogol 4000 52,500 g + Sodium sulphate anhydrous 3,750 g + Simethicone 0,080 g) split dose

Taking the colonoscopy preparation drug (Clensia) in two stages of administration

Sponsors & Collaborators

  • Presidio Ospedaliero Sant Ottone Frangipane Avellino

    collaborator UNKNOWN
  • Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

    collaborator OTHER
  • Azienda Policlinico Umberto I

    collaborator OTHER
  • Ospedale di Manerbio ASST Garda

    collaborator UNKNOWN
  • Ospedale Civile San Giovanni di Dio Crotone

    collaborator UNKNOWN
  • Ospedale di Baggiovara Modena

    collaborator UNKNOWN
  • Ospedale S. Jacopo Pistoia

    collaborator UNKNOWN
  • Ospedale S. Martino Belluno

    collaborator UNKNOWN
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER
  • Federico II University

    collaborator OTHER
  • Societa Italiana di Endoscopia Digestiva

    lead OTHER

Principal Investigators

  • LUIGI PASQUALE, PROF · Societa Italiana di Endoscopia Digestiva

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2021-12-28
Completion
2021-12-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570669 on ClinicalTrials.gov